The FAA clearance of the small RKN container follows the certification of the bigger Opticooler RAP, which is already well-established in the United States.

Both containers have previously been utilised by non-US airlines for active air cargo transportation on US routes. With this FAA approval, any airline operating in the United States may now have both DoKaSch Temperature Solutions Opticooler containers technically approved and verified.

"The FAA’s approval of the Opticooler RKN has been well received by the US pharma industry, as it can now also choose US-based airlines to utilize the RAP and RKN, depending upon its needs. This last gap in serving that market has been closed by DoKaSch TS extending its entire Opticooler fleet to all US-based airlines, enabling them to now also service their home market for international shipment," said Andreas Seitz, Managing Director of DoKaSch Temperature Solutions.

Airlines and forwarders in the United States can now meet the growing demand for extremely secure and dependable cold chain solutions for temperature-sensitive pharmaceuticals. Initial technical clearances are presently being processed by US-based airlines, allowing them to transport not only the RAP, but also the RKN in their home market.

Click here to read more.

Click Here For More Stories